JP2011518838A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518838A5
JP2011518838A5 JP2011506465A JP2011506465A JP2011518838A5 JP 2011518838 A5 JP2011518838 A5 JP 2011518838A5 JP 2011506465 A JP2011506465 A JP 2011506465A JP 2011506465 A JP2011506465 A JP 2011506465A JP 2011518838 A5 JP2011518838 A5 JP 2011518838A5
Authority
JP
Japan
Prior art keywords
chitosan
fluid layer
pharmaceutical composition
oxidized polysaccharide
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506465A
Other languages
English (en)
Japanese (ja)
Other versions
JP5833919B2 (ja
JP2011518838A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041591 external-priority patent/WO2009132227A1/en
Publication of JP2011518838A publication Critical patent/JP2011518838A/ja
Publication of JP2011518838A5 publication Critical patent/JP2011518838A5/ja
Application granted granted Critical
Publication of JP5833919B2 publication Critical patent/JP5833919B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506465A 2008-04-24 2009-04-23 キトサンと酸化多糖とに基づく保護用ゲル Expired - Fee Related JP5833919B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4759008P 2008-04-24 2008-04-24
US61/047,590 2008-04-24
PCT/US2009/041591 WO2009132227A1 (en) 2008-04-24 2009-04-23 Protective gel based on chitosan and oxidized polysaccharide

Publications (3)

Publication Number Publication Date
JP2011518838A JP2011518838A (ja) 2011-06-30
JP2011518838A5 true JP2011518838A5 (https=) 2012-05-31
JP5833919B2 JP5833919B2 (ja) 2015-12-16

Family

ID=40821728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506465A Expired - Fee Related JP5833919B2 (ja) 2008-04-24 2009-04-23 キトサンと酸化多糖とに基づく保護用ゲル

Country Status (8)

Country Link
US (2) US9433636B2 (https=)
EP (1) EP2310002B1 (https=)
JP (1) JP5833919B2 (https=)
CN (1) CN102065849B (https=)
AU (1) AU2009240512B2 (https=)
CA (1) CA2721937C (https=)
ES (1) ES2610881T3 (https=)
WO (1) WO2009132227A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
WO2009132229A2 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Cold ionizing radiation sterilization
CA2780898A1 (en) 2009-11-13 2011-05-19 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
US9700648B2 (en) 2010-10-27 2017-07-11 Medtronic, Inc. Artificial scab for use in an airway
US8974436B2 (en) 2011-10-28 2015-03-10 Medtronic Xomed, Inc. Multi-sectioned cannula with multiple lumens
US20130105018A1 (en) 2011-10-28 2013-05-02 Medtronic Xomed, Inc. Turbulence-inducing mixing device
US9486190B2 (en) 2011-10-28 2016-11-08 Medtronic Xomed, Inc. Spray delivery system
US10441959B2 (en) 2011-10-28 2019-10-15 Medtronic Xomed, Inc. Multi-orifice spray head
CA2877725C (en) * 2012-06-28 2024-01-02 The Administrators Of The Tulane Educational Fund Selectively polymerizable compositions and methods of use in vivo
RU2526183C1 (ru) * 2013-02-28 2014-08-20 Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства (ФГУП НПЦ "Фармзащита" ФМБА России) Гемостатическая противоожоговая ранозаживляющая композиция
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
CN103275338B (zh) * 2013-06-08 2016-01-13 广东海洋大学 一种采用戊二醛提高江蓠琼胶凝胶强度的方法
US9480828B2 (en) 2013-11-14 2016-11-01 Gyrus Acmi, Inc. Treatment method for the inferior turbinate
EP3139903B1 (en) 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
US20150359923A1 (en) * 2014-06-15 2015-12-17 Monitex Industrial Co., Ltd. Method Of Manufacturing Biodegradable Materials For Filling Nasal Cavity
DE102014009012A1 (de) * 2014-06-17 2015-12-17 Monitex Industrial Co., Ltd. Eine Methode zur Herstellung bioabbaubarer Materialien als Nasenhöhlenfüllung
FR3033498B1 (fr) * 2015-03-12 2018-03-23 L'oreal Procede de protection et de reparation des fibres keratiniques a partir de polysaccharide oxyde et de (poly)saccharide a groupe amine
EP4233873A3 (en) 2015-06-29 2023-10-18 Lyra Therapeutics, Inc. Implantable scaffolds for treatment of sinusitis
US10159586B2 (en) 2015-06-29 2018-12-25 480 Biomedical Inc. Scaffold loading and delivery systems
US10232082B2 (en) 2015-06-29 2019-03-19 480 Biomedical, Inc. Implantable scaffolds for treatment of sinusitis
KR20180066240A (ko) 2015-10-30 2018-06-18 크로마-파르마 게젤샤프트 엠.베.하. 무균 수성 안과용 액제의 치료적 용도
RU2741912C2 (ru) 2015-10-30 2021-01-29 Крома-Фарма Гезелльшафт М.Б.Х. Применение в терапии стерильного водного офтальмологического раствора
US10973664B2 (en) 2015-12-30 2021-04-13 Lyra Therapeutics, Inc. Scaffold loading and delivery systems
TWI769136B (zh) * 2016-06-23 2022-07-01 美商克利斯朗公司 高效用止血黏著性聚合物支架
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
US10201639B2 (en) 2017-05-01 2019-02-12 480 Biomedical, Inc. Drug-eluting medical implants
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
CN109513043A (zh) * 2017-09-20 2019-03-26 刘宏飞 一种注射用修饰透明质酸钠凝胶及其制备方法
CN107814981B (zh) * 2017-11-09 2020-09-22 四川艾医生医疗科技有限公司 一种壳聚糖水凝胶敷料及其制备方法
AU2018389853B2 (en) 2017-12-20 2024-10-31 Stryker European Operations Holdings Llc Biomedical foam
WO2020106703A1 (en) 2018-11-19 2020-05-28 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
CN109602686A (zh) * 2019-02-02 2019-04-12 西安力邦制药有限公司 一种水凝胶化妆品组合物及其制备方法
CN110251721A (zh) * 2019-08-02 2019-09-20 山东百多安医疗器械有限公司 一种原位成型自修复抗菌水凝胶及其制备方法
US20210077383A1 (en) * 2019-09-17 2021-03-18 Topical Sinus Therapeutics, Inc. Therapeutic uses and methods of delivery of viscous compositions during pre and post surgical periods, for treatment of responsive diseases of the ear, nose, and throat
US11305387B2 (en) 2019-11-04 2022-04-19 Covidien Lp Systems and methods for treating aneurysms
CN111110926B (zh) * 2020-02-11 2022-04-01 南通大学 一种用于消化道粘膜分层的可注射有色凝胶垫及其应用
US12048575B2 (en) * 2020-03-10 2024-07-30 GE Precision Healthcare LLC Systems and methods for registration of angiographic projections with computed tomographic data
EP4308013A1 (en) 2021-03-16 2024-01-24 Covidien LP Injectable biopolymer compositions and associated systems and methods
CN120000580B (zh) * 2025-03-03 2025-11-21 广州医科大学 一种水凝胶系统及其制备方法和应用

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184385A (en) 1961-10-16 1965-05-18 Eastman Kodak Co Dry, vitamin-active product and process for preparing same
US3678931A (en) 1970-06-09 1972-07-25 Milton J Cohen Syringe
US3914214A (en) 1973-08-24 1975-10-21 Us Agriculture Thiolation of polysaccharides
US3989044A (en) 1975-08-11 1976-11-02 Warner-Lambert Company Syringe
JPS59501159A (ja) 1982-06-24 1984-07-05 スミス、ロバ−ト・アラン 薬用ゲル組成物
US4659700A (en) 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
US4895724A (en) 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
US4960413A (en) 1985-11-09 1990-10-02 The Shirley Institute Wound dressing
JPS62123112A (ja) 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
JPH07116241B2 (ja) 1989-02-08 1995-12-13 サッポロビール株式会社 米糠由来生理活性多糖ronの製造法
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
GB9105995D0 (en) 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5308546A (en) 1991-12-09 1994-05-03 Glow-Tec Phosphorescent toy gel composition and methods of manufacture
US5550189A (en) 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
US6197346B1 (en) 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5312324A (en) 1992-09-15 1994-05-17 Walthour Charles D Nasal dressing system
GB2276819B (en) 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5531716A (en) 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US5622834A (en) 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
GB9416884D0 (en) 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
CA2215978A1 (en) 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US5679658A (en) 1995-05-08 1997-10-21 Chitogenics, Inc. N,O-carbonxymethylchitosan for prevention of surgical adhesions
US6320029B1 (en) 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
WO1997022371A1 (en) 1995-12-18 1997-06-26 Collagen Corporation Crosslinked polymer compositions and methods for their use
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
IL118376A0 (en) 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
IN192791B (https=) 1996-06-28 2004-05-22 Johnson & Johnson Medical
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US6545042B2 (en) 1996-11-05 2003-04-08 Gp Medical Acellular biological material chemically treated with genipin
WO1998019718A1 (en) 1996-11-05 1998-05-14 Challenge Bioproducts Co., Ltd. Chemical modification of biomedical materials with genipin
ATA7997A (de) 1997-01-21 1998-03-15 Bernkop Schnuerch Andreas Verfahren zur herstellung von chitosan-ethylendiamintetraacetat konjugaten
US5770712A (en) 1997-03-14 1998-06-23 Virginia Tech Intellectual Properties, Inc. Crosslinked hydrogel beads from chitosan
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US20050096282A1 (en) 1997-04-21 2005-05-05 Lewin Alfred S. Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases
US20030073663A1 (en) 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
ATE247990T1 (de) 1997-07-02 2003-09-15 Coloplast As Herstellungsmethode für ein faserfreies, poröses material
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
DE69831421T2 (de) 1997-12-02 2006-06-22 Archimedes Development Ltd. Zusammensetzungen zur nasalen verabreichung
US6514522B2 (en) 1998-04-08 2003-02-04 Chondros, Inc. Polymer constructs
EP1108423B1 (en) 1998-08-26 2005-03-30 Teijin Limited Powdery pernasal compositions
JP2000095678A (ja) 1998-09-22 2000-04-04 Dai Ichi Kogyo Seiyaku Co Ltd パップ剤用基剤およびそれを含有するパップ剤
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
JP4606586B2 (ja) 1998-11-10 2011-01-05 株式会社ネーテック 機能性キトサン誘導体
JP2002531217A (ja) 1998-12-04 2002-09-24 チャンドラシェカー ピー. パサック, 生体適合性架橋ポリマー
BR0007296A (pt) 1999-01-04 2002-02-05 Biomm Inc Novas formulações poliméricas contendo compostos perfluorados para a engenharia de células e tecidos para transplantes que melhoram o metabolismo e a sobrevivência celular, e métodos para a sua produção
US6645947B1 (en) 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
EP1223986A2 (en) 1999-06-11 2002-07-24 Shearwater Corporation Hydrogels derived from chitosan and poly(ethylene glycol)
AU782519B2 (en) 1999-11-09 2005-08-04 Denki Kagaku Kogyo Kabushiki Kaisha Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same
BR0109162A (pt) 2000-03-14 2005-01-11 Alcon Inc Viscoelásticos para uso na cirurgia do ouvido médio
WO2004087227A1 (en) 2003-04-04 2004-10-14 Tissuemed Limited Tissue-adhesive formulations
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
DE10035799A1 (de) * 2000-07-22 2002-01-31 Kalle Nalo Gmbh & Co Kg Nach dem Aminoxidverfahren hergestellte Nahrungsmittelhüllen auf Cellulosebasis
GB0018527D0 (en) 2000-07-27 2000-09-13 Photocure Asa Composition
US6417347B1 (en) 2000-08-24 2002-07-09 Scimed Life Systems, Inc. High yield S-nitrosylation process
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
US6989373B2 (en) 2000-11-15 2006-01-24 Bio Syntech Canada Inc. Method for restoring a fat-pad
AU2001298061A1 (en) 2000-12-13 2003-07-09 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
JP2004529929A (ja) 2001-04-23 2004-09-30 ニュクリスト ファーマシューティカルズ コーポレーション アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用
JP3611534B2 (ja) 2001-04-26 2005-01-19 株式会社エス・エヌ・シー 高分子包接性化合物からなる有害物質除去のための繊維およびその製造方法ならびに使用
EP1392182A1 (en) 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
ATA13842001A (de) 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
DE10152407A1 (de) * 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
EP1448607B1 (en) 2001-11-15 2011-01-05 Biosyntech Canada Inc. Composition and method to homogeneously modify or cross-link chitosan under neutral conditions
WO2003057274A2 (en) 2001-12-28 2003-07-17 Genzyme Corporation Bioresorbable foam packing device and use thereof
US6664301B1 (en) 2002-02-20 2003-12-16 Robert D. Kross Method for using glycol additives to texturally modify natural gum hydrogels
GB2386900B (en) 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
CA2484453A1 (en) 2002-04-23 2003-11-06 Netech Inc. Medicinal compositions containing photocrosslinkable chitosan derivative
JP4321007B2 (ja) * 2002-04-25 2009-08-26 凸版印刷株式会社 多糖類複合体及びその製造方法
EP1539799B1 (en) 2002-06-21 2013-12-11 The University of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
WO2003091128A1 (en) 2002-06-26 2003-11-06 Daizo Co.,Ltd. Packaging container for discharge of plurality of contents, packaging product including the packaging container and process for producing the packaging product
US20050019404A1 (en) 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
US7070582B2 (en) 2002-08-09 2006-07-04 Boston Scientific Scimed, Inc. Injection devices that provide reduced outflow of therapeutic agents and methods of delivering therapeutic agents
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8673333B2 (en) 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
US7862831B2 (en) 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
JP5102435B2 (ja) 2002-10-08 2012-12-19 株式会社リコム キトサン含有多糖、その製造方法及び用途
US20050069572A1 (en) 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
TWI251596B (en) 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
KR100470753B1 (ko) 2003-01-09 2005-03-10 주식회사 자광 수용성 천연필름과 그의 제조방법
CN1278785C (zh) 2003-02-25 2006-10-11 株式会社家味 除臭、抗菌、防真菌剂的喷涂方法及经除臭、抗菌、防真菌处理过的物品
DE10318802A1 (de) 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Selbsthaftendes resorbierbares Hämostyptikum
WO2005000374A1 (ja) 2003-06-30 2005-01-06 Denki Kagaku Kogyo Kabushiki Kaisha 脊椎・脊髄手術用癒着防止材
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
WO2005087221A1 (en) 2004-03-15 2005-09-22 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
AU2005263729B2 (en) 2004-07-22 2011-01-06 Bey Pharma GmbH Use of compounds containing thiol groups as an efflux pump inhibitor
US7282194B2 (en) 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US8703659B2 (en) * 2005-01-24 2014-04-22 Halliburton Energy Services, Inc. Sealant composition comprising a gel system and a reduced amount of cement for a permeable zone downhole
US7834065B2 (en) 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
WO2006092799A1 (en) 2005-03-02 2006-09-08 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
AU2006244873A1 (en) 2005-05-13 2006-11-16 Netech Inc. Medical composition for promotion of skin regeneration
DE102005030011A1 (de) 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
US20070031467A1 (en) * 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
US20070087059A1 (en) 2005-10-17 2007-04-19 Frank Everaerts Bioactive delivery matrix compositions and methods
US20070110788A1 (en) 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
GB0526136D0 (en) 2005-12-22 2006-02-01 Unilever Plc Antiperspirant compositions
AU2007207429A1 (en) 2006-01-19 2007-07-26 Warsaw Orthopedic, Inc. Injectable and moldable bone substitute materials
FR2897775B1 (fr) 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
JP2009533455A (ja) 2006-04-12 2009-09-17 マサチューセッツ インスティテュート オブ テクノロジー 癒着を阻害するための組成物および方法
US20090010982A1 (en) 2006-04-18 2009-01-08 Endomedix, Inc. Biocompatible adherent sheet for tissue sealing
US20070243130A1 (en) 2006-04-18 2007-10-18 Weiliam Chen Biopolymer system for tissue sealing
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
US7854923B2 (en) 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
CN100348272C (zh) 2006-06-23 2007-11-14 华南理工大学 可溶性纤维素止血海绵的制备方法
US8313762B2 (en) 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
CN101511875A (zh) 2006-07-11 2009-08-19 犹他大学研究基金会 硫醇化的大分子及其制备方法和应用
WO2008067655A1 (en) * 2006-12-05 2008-06-12 Q6 Biomaterials Inc. Biocompatible hydrogel-based scaffolds
JP2008247975A (ja) 2007-03-29 2008-10-16 Daicel Chem Ind Ltd 架橋ゲルおよびそれを用いた吸収体
JP2008285611A (ja) 2007-05-18 2008-11-27 Daicel Chem Ind Ltd 架橋ゲルの製造方法及びその架橋ゲル
JP2009040697A (ja) 2007-08-07 2009-02-26 Asuka Corporation:Kk 化粧料組成物
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
KR101610268B1 (ko) 2007-08-28 2016-04-07 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 외과용 하이드로겔

Similar Documents

Publication Publication Date Title
JP2011518838A5 (https=)
Jiang et al. Chitosan as a biomaterial: structure, properties, and applications in tissue engineering and drug delivery
JP2011518839A5 (https=)
JP2011522879A5 (https=)
WO2013167098A3 (en) Method of preparation of polysaccharide fibers, wound covers that contain them, method of manufacturing of wound covers, and apparatus for preparation of polysaccharide fibers
EP2671584A3 (en) Compositions and methods for treating disorders associated with salt or fluid retention
MX2014000141A (es) Agentes de enlace a receptor de canabinoide, composiciones y metodos.
BR112015013774A2 (pt) membrana de hidrogel para prevenção de adesão
IL195316A0 (en) Nanoparticles of chitosan and hyaluronan for the administration of active molecules
WO2008039827A3 (en) Polymer systems for lung volume reduction therapy
UA98125C2 (ru) Замещенные дигидропиразолоны для лечения сердечно-сосудистых и гематологических заболеваний
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
WO2011092715A3 (en) Method for in-vivo binding of chromatin fragments
WO2007098106A3 (en) Respiratory tract delivery of interferon-tau
Ma et al. A review of polysaccharide hydrogels as materials for skin repair and wound dressing: Construction, functionalization and challenges
WO2010078036A3 (en) Biocompatible polysaccharide-based hydrogels
BRPI0810384B8 (pt) terapia enzimática anticâncer
WO2007006403A3 (en) Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process
BR112015010842A8 (pt) uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
WO2010042701A3 (en) Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
Chen et al. Progress in polysaccharide-based hydrogels for preventing postoperative adhesions: a review
CA2787512C (en) A method of treating sinusitis, including chronic sinusitis
CN106390178A (zh) 一种医用天然海洋生物敷料
SI2555770T1 (en) Ketorolac compositions for corneal wound healing
WO2007089688A3 (en) Na/k-atpase ligand